Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05586477Phase 4Completed
A Phase 4 trial of diphenhydramine in allergic rhinitis (AR), sponsored by Lakehead University. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05586477.